Campomanes, Angelly R.

HRN: 10-53-48  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/22/2022
CEFUROXIME 500MG (TAB)
06/22/2022
06/29/2022
PO
500mg
Q12
Uti
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: No  Wrong Route  Wrong Route

Overall appropriateness: No  Wrong Route

Intervention



Type of Intervention done:

                    

           


Acceptance: